Png C Y Maximilian, Pendleton A Alaska, Altreuther Martin, Budtz-Lilly Jacob W, Gunnarsson Kim, Kan Chung-Dann, Khashram Manar, Laine Matti T, Mani Kevin, Pederson Christian C, Srivastava Sunita D, Eagleton Matthew J
Division of Vascular and Endovascular Surgery, Department of Surgery, Massachusetts General Hospital, Boston, MA 02114, USA.
Department of Vascular Surgery, St. Olavs Hospital, 7030 Trondheim, Norway.
J Clin Med. 2024 Apr 23;13(9):2464. doi: 10.3390/jcm13092464.
: We sought to investigate the differential impact of EVAR (endovascular aneurysm repair) vis-à-vis OSR (open surgical repair) on ruptured AAA (abdominal aortic aneurysm) mortality by sex and geographically. : We performed a retrospective study of administrative data on EVAR from state statistical agencies, vascular registries, and academic publications, as well as ruptured AAA mortality rates from the World Health Organization for 14 14 states across Australasia, East Asia, Europe, and North America. : Between 2011-2016, the proportion of treatment of ruptured AAAs by EVAR increased from 26.1 to 43.8 percent among females, and from 25.7 to 41.2 percent among males, and age-adjusted ruptured AAA mortality rates fell from 12.62 to 9.50 per million among females, and from 34.14 to 26.54 per million among males. The association of EVAR with reduced mortality was more than three times larger (2.2 vis-à-vis 0.6 percent of prevalence per 10 percentage point increase in EVAR) among females than males. The association of EVAR with reduced mortality was substantially larger (1.7 vis-à-vis 1.1 percent of prevalence per 10 percentage point increase in EVAR) among East Asian states than European+ states. : The increasing adoption of EVAR coincided with a decrease in ruptured AAA mortality. The relationship between EVAR and mortality was more pronounced among females than males, and in East Asian than European+ states. Sex and ethnic heterogeneity should be further investigated.
我们试图从性别和地域角度,研究血管内动脉瘤修复术(EVAR)与开放手术修复术(OSR)相比,对破裂性腹主动脉瘤(AAA)死亡率的不同影响。我们对来自国家统计机构、血管登记处和学术出版物的EVAR行政数据,以及来自世界卫生组织的澳大拉西亚、东亚、欧洲和北美的14个州的破裂性AAA死亡率进行了回顾性研究。在2011年至2016年期间,女性中采用EVAR治疗破裂性AAA的比例从26.1%增至43.8%,男性中这一比例从25.7%增至41.2%,年龄调整后的女性破裂性AAA死亡率从每百万12.62降至9.50,男性则从每百万34.14降至26.54。与男性相比,女性中EVAR与死亡率降低的关联大三倍多(EVAR每增加10个百分点,患病率分别为2.2%和0.6%)。与欧洲及其他地区国家相比,东亚国家中EVAR与死亡率降低的关联显著更大(EVAR每增加10个百分点,患病率分别为1.7%和1.1%)。EVAR应用的增加与破裂性AAA死亡率的降低同时出现。EVAR与死亡率之间的关系在女性中比男性中更明显,在东亚比欧洲及其他地区国家更明显。性别和种族异质性应进一步研究。